Summary
Updated Aug 30, 2026
Anne Prener files SEC Form 4 reports at Keros Therapeutics, Inc. (KROS). 1 SEC Form 4 filing on record, dated 6 July 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Anne Prener has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Anne Prener files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $95.66M of KROS open-market activity in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M of KROS open-market activity in the last 12 months
- Esther Cho - $124K of KROS open-market activity in the last 12 months
- Jasbir Seehra - $113K of KROS open-market activity in the last 12 months
- Lorena Raquel Lerner - $100K of KROS open-market activity in the last 12 months
- Keith Regnante - $77K of KROS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Anne Prener?
Anne Prener is a corporate insider of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anne Prener submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Anne Prener's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Anne Prener and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
